2 hours ago
Biogen (BIIB) Expands Immunology Portfolio with $1B RayThera Acquisition
Biogen (BIIB) stock dips after unveiling $1B RayThera acquisition to strengthen immunology pipeline with anti-inflammatory drug candidates.
The post Biogen (BIIB) Expands Immunology Portfolio with $1B RayThera Acquisition appeared first on Blockonomi.
Source: Blockonomi →Related News
- 40 minutes ago
D-Wave (QBTS) Shares Decline Following Gate-Model Quantum Simulator Reveal
- 47 minutes ago
IonQ (IONQ) Stock Rises on Quantum Computing Breakthrough and 754% Revenue Growt...
- 47 minutes ago
BYD Stock (BYDDF): Will Formula One Sponsorship Fuel Global Expansion?
- 48 minutes ago
Snowflake (SNOW) Stock Gains Momentum with $345M Institutional Investment and Up...
- 49 minutes ago
Intel (INTC) Stock Jumps 9% on Apple Partnership News; Rumble Soars 17%